financetom
Business
financetom
/
Business
/
Telos Achieves StateRAMP High Authorization for Xacta SaaS Platform
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Telos Achieves StateRAMP High Authorization for Xacta SaaS Platform
Jan 21, 2025 10:38 AM

01:23 PM EST, 01/21/2025 (MT Newswires) -- Telos ( TLS ) said Tuesday it has achieved State Risk and Authorization Management Program high authorization for its software-as-a-service version of Xacta platform.

Xacta SaaS is now included in the StateRAMP Authorized Product List, with an authorized status, the highest level of authorization given to products that have complied with all required security controls by impact level, according to StateRAMP.

Telos ( TLS ) said Xacta SaaS' authorized status is expected to boost its growth in the state and local government markets.

Shares of Telos ( TLS ) were up 1.2% in recent Tuesday trading.

Price: 3.35, Change: +0.04, Percent Change: +1.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Oracle-backed Ampere Reportedly Considering Sale
Market Chatter: Oracle-backed Ampere Reportedly Considering Sale
Sep 25, 2024
08:53 AM EDT, 09/19/2024 (MT Newswires) -- Oracle-backed (ORCL) Ampere Computing is exploring a potential sale, Bloomberg reported Thursday, citing people with knowledge of the matter. The chip designer has been fielding interest from potential suitors with the help of a financial advisor, according to the report. Discussions are ongoing and the company could remain independent, though it is no...
Oppenheimer Holdings to Redeem $113 Million of Senior Notes Due 2025
Oppenheimer Holdings to Redeem $113 Million of Senior Notes Due 2025
Sep 25, 2024
10:40 AM EDT, 09/19/2024 (MT Newswires) -- Oppenheimer Holdings ( OPY ) said Thursday it sent a notice to holders of its 5.50% senior secured notes due 2025, indicating its intent to redeem about $113.1 million on Oct. 10. The redemption price will be 100% of the principal amount, plus any accrued and unpaid interest, the company said. Once the...
BRIEF-BioAge Labs Announces Pricing Of Upsized Initial Public Offering Of 11 Million Shares At $18.00 Per Share
BRIEF-BioAge Labs Announces Pricing Of Upsized Initial Public Offering Of 11 Million Shares At $18.00 Per Share
Sep 25, 2024
Sept 25 (Reuters) - * BIOAGE LABS ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING * BIOAGE LABS, INC- ANNOUNCED PRICING OF UPSIZED INITIAL PUBLIC OFFERING OF 11 MILLION SHARES AT A PUBLIC OFFERING PRICE OF $18.00 PER SHARE Source text for Eikon: ...
Weight-loss drug developer BioAge raises $198 mln in US IPO
Weight-loss drug developer BioAge raises $198 mln in US IPO
Sep 25, 2024
Sept 25 (Reuters) - BioAge Labs has raised $198 million after pricing its upsized U.S. initial public offering at the midpoint of the range at $18 per share, the weight-loss drug developer said on Wednesday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved